Topics

Disarm Therapeutics Names Scott Holmes Chief Financial Officer

19:22 EST 15 Jan 2020 | Xconomy

Disarm Therapeutics has appointed Scott Holmes to serve as its chief financial officer, the same position he held most recently at Kiadis Pharma. Before working at Kiadis, Holmes was the CFO of Keryx Biopharmaceuticals. Cambridge, MA-based Disarm is developing drugs neurodegenerative disease drugs that target a protein called SARM1.

Original Article: Disarm Therapeutics Names Scott Holmes Chief Financial Officer

NEXT ARTICLE

More From BioPortfolio on "Disarm Therapeutics Names Scott Holmes Chief Financial Officer"

Quick Search

Relevant Topic

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...